Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection
Open Access
- 23 December 2012
- journal article
- research article
- Published by Springer Nature in The Patient - Patient-Centered Outcomes Research
- Vol. 5 (4) , 265-278
Abstract
Some patients with chronic hepatitis C virus (HCV) infection forego treatment due to concerns about treatment efficacy, treatment duration, and side effects.Keywords
This publication has 47 references indexed in Scilit:
- Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease ProgressionGastroenterology, 2010
- Hepatitis C Drug Development at a Crossroads†Hepatology, 2009
- Patients’ Preferences for Treatment of Hepatitis CMedical Decision Making, 2009
- Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose‐lowering agentsDiabetic Medicine, 2009
- Predictors of treatment in patients with chronic hepatitis C infection—Role of patient versus nonpatient factorsHepatology, 2007
- Reasons Why Patients Infected with Chronic Hepatitis C Virus Choose to Defer Treatment: Do They Alter Their Decision with Time?Digestive Diseases and Sciences, 2007
- Rate and predictors of treatment prescription for hepatitis CGut, 2006
- Barriers to the treatment of hepatitis CJournal of General Internal Medicine, 2005
- The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis CJournal of Hepatology, 2004
- Duration neglect in retrospective evaluations of affective episodes.Journal of Personality and Social Psychology, 1993